Skip to content
Open access

Oxygen-Embedded Fused-Ring Structure for NIR-Triggered Multimodal Phototherapy of Laryngeal Cancer.

Jul 2026 · ACS Applied Materials and Interfaces · Vol 18 31, pp. 42332-42344 · 0 citations · 61 references
Medicine

TL;DR

An oxygen-embedded fused-ring organic semiconductor formulated into multifunctional nanoparticles for near-infrared (NIR)-triggered multimodal phototherapy of laryngeal cancer highlights the potential of this system as a promising platform for multimodal phototherapy of laryngeal cancer.

Abstract

Laryngeal cancer requires precise and minimally invasive therapeutic strategies to preserve critical physiological functions. Herein, an oxygen-embedded fused-ring organic semiconductor (COi8FIC) was reported, which is formulated into multifunctional nanoparticles for near-infrared (NIR)-triggered multimodal phototherapy. The incorporation of oxygen atoms into the conjugated backbone, together with fluorinated cyanoindanone end-groups, narrows the bandgap to 1.35 eV and enhances intramolecular charge transfer, thereby promoting non-radiative decay and intersystem crossing. As a result, COi8FIC nanoparticles exhibit a high photothermal conversion efficiency of 62% and generate multiple reactive oxygen species (•OH, O2-, and 1O2) via synergistic Type I and Type II photodynamic pathways. In vitro, the nanoparticles produce approximately 2.5-fold higher ROS levels than monotherapies. In vivo, NIR irradiation induces rapid hyperthermia (ΔT ca. 23.6 °C), resulting in a tumor growth inhibition rate of 93.3%. Tumor regression was observed in all treated mice, with complete tumor eradication in three of five mice and near-complete elimination in the remaining two, with no significant irreversible organ damage. These results highlight the potential of this system as a promising platform for multimodal phototherapy of laryngeal cancer.

Read PDF

Similar papers

Aug 2026

Metal-organic cage-mediated synergistic tumor microenvironment remodeling and self-enhanced photodynamic therapy.

In vivo antitumor studies demonstrate that PFD released in situ remodels TME by downregulating hyaluronic acid and type I collagen expression, normalizing tumor vasculature, improving intratumoral oxygen perfusion and contributing to amplified PDT.

Jingjing Jiao, Yibing Wang, Kangkang Huang et al. · 0 citations
Aug 2026

Zwitterionic Polarization‐Engineering Covalent Organic Frameworks for Targeted Ferroptosis‐Synergistic Photothermal Immunotherapy

This study constructed two isomorphic frameworks featuring distinct electronic topologies: a zwitterionic squaric acid (SA) COF with inherent electrostatic asymmetry, and a charge‐neutral terephthaldehyde (TA) COF, which eliminates primary tumors, produces abscopal effects, and establishes immune memory against recurre...

Jiarong Liang, Silu Wang, Zhong-Hui Ma et al. · 0 citations
Oct 2026

Supramolecular Nanoparticles Based on Galactose Functionalized Pillar[5]arene for Synergistic Photothermal/Photodynamic/CO Gas Multimodal Cancer Therapy

Gas therapy based on carbon monoxide (CO) is an emerging anticancer strategy. However, conventional CO donors suffer from uncontrolled gas release and poor therapeutic efficacy. Developing a multimodal therapeutic system combining CO gas therapy and phototherapy modalities, which is of great significance for improvin...

Hao-Sen Wang, Shi-Han Xu, Cong Li et al. · 0 citations
Sep 2026

Near-Infrared Laser-Responsive Nanoplatform for Photodynamic/Photothermal/Chemodynamic Combined Therapy

Surgical resection remains a conventional clinical strategy for melanoma treatment, yet it still suffers from considerable clinical bottlenecks, including difficult surgical operations and unintended damage to adjacent normal tissues. Herein, a multifunctional nanoplatform, CeO2-ICG@PDA (CeICP NPs), was constructed....

Han Hu, Shi-Jie Yao, Hao Jia et al. · 0 citations
Open access Aug 2026

Construction of mannosylated glycol-nanoparticles for near-infrared bioimaging and photodynamic therapy targeting breast cancer cells

Two donor–π–acceptor type photosensitizers, TC1 and TC2, are designed by bridging electron-rich carbazole with electron-withdrawing tricyanofuran (TCF) via thiophene or EDOT moieties as promising targeted theranostic agents for NIR imaging and PDT of breast cancer.

Yu Tang, Zhuo Song, Lu-Lu Sun et al. · 0 citations
Open access Aug 2026

Integrating perfluorocarbon and type-I photosensitizer into a single molecule: a phenothiazine-based platform for hypoxia-tolerant PDT

Both in vitro and in vivo studies confirm that PFI effectively accumulates in tumors, relieves hypoxia, and achieves potent antitumor efficacy with negligible side effects, offering a facile and robust platform for hypoxia-tolerant photodynamic cancer therapy.

Ziqi Zou, Mei-Ying Liu, Kun Zhang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.